We are live on ! Find out more
ICU icon

SeaStar Medical
ICU

26 hedge funds and large institutions have $205K invested in SeaStar Medical in 2025 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 3

0% more funds holding

Funds holding: 26 → 26 (0)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

0.61% less ownership

Funds ownership: 1.04% → 0.43% (-0.61%)

86% less capital invested

Capital invested by funds: $1.5M → $205K (-$1.29M)

Holders
26
Holders Change
–
Holders Change %
0%
% of All Funds
0.34%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
6
Reduced
3
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$105K
2
XT
XTX Topco
Cayman Islands
+$56.1K
3
VF
Virtu Financial
New York
+$43.6K
4
PNC Financial Services Group
PNC Financial Services Group
Pennsylvania
+$11.5K
5
TFA
Trinity Financial Advisors
Ohio
+$5.76K

Top Sellers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
-$1.02M
2
Geode Capital Management
Geode Capital Management
Massachusetts
-$6.7K
3
Osaic Holdings
Osaic Holdings
Arizona
-$346
4
CAWM
Capital A Wealth Management
Pennsylvania
-$239
5
Morgan Stanley
Morgan Stanley
New York
-$69
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS Group
1
UBS Group
Switzerland
$39K +$105K +9,149 New
Geode Capital Management
2
Geode Capital Management
Massachusetts
$29.3K -$6.7K -581 -8%
XT
3
XTX Topco
Cayman Islands
$26K +$56.1K +4,867 +395%
Vanguard Group
4
Vanguard Group
Pennsylvania
$24.5K – – –
TWP
5
Tyche Wealth Partners
Texas
$16K – – –
VF
6
Virtu Financial
New York
$16K +$43.6K +3,783 New
Raymond James Financial
7
Raymond James Financial
Florida
$15.9K – – –
PNC Financial Services Group
8
PNC Financial Services Group
Pennsylvania
$6.59K +$11.5K +1,000 +182%
TFA
9
Trinity Financial Advisors
Ohio
$6.39K +$5.76K +500 +50%
Northern Trust
10
Northern Trust
Illinois
$5.44K – – –
Goldman Sachs
11
Goldman Sachs
New York
$5.29K +$2.56K +222 +22%
GVAG
12
Great Valley Advisor Group
Delaware
$4K – – –
BlackRock
13
BlackRock
New York
$3.88K – – –
TRCT
14
Tower Research Capital (TRC)
New York
$2.32K +$4.09K +355 +187%
WT
15
Whittier Trust
California
$2.1K – – –
Osaic Holdings
16
Osaic Holdings
Arizona
$964 -$346 -30 -12%
BTI
17
Blue Trust Inc
Georgia
$378 – – –
Morgan Stanley
18
Morgan Stanley
New York
$359 -$69 -6 -7%
NA
19
NewEdge Advisors
Louisiana
$116 – – –
TWC
20
TD Waterhouse Canada
Ontario, Canada
$105 – – –
GPFA
21
Game Plan Financial Advisors
Ohio
$43 – – –
Bank of America
22
Bank of America
North Carolina
$43 +$46 +4 +67%
SS
23
SBI Securities
Japan
$40 – – –
SWA
24
SOA Wealth Advisors
New York
$23 – – –
HWM
25
HighMark Wealth Management
Minnesota
$9 – – –
1
2

ICU Hedge Fund Activity: Q2 2025 in Review

26 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in SeaStar Medical (ICU) for Q2 2025, worth a combined $205K — down 86% from $1.5M a quarter earlier.

Fund positioning in ICU was balanced in Q2 2025: 2 funds opened new positions, 2 closed out, 6 added to existing stakes and 3 trimmed.

The largest buyer was UBS Group, opening a new position worth an estimated $105K. The largest seller was Armistice Capital, exiting entirely with an estimated $1.02M sold.

  • 26 institutional investors held SeaStar Medical (ICU) as of Q2 2025, unchanged from Q1 2025.
  • Funds reported $205K of SeaStar Medical stock for Q2 2025, down 86% quarter-over-quarter.
  • 2 funds opened new SeaStar Medical positions in Q2 2025 and 2 closed out, a net change of 0 holders.
  • The largest SeaStar Medical buyer in Q2 2025 was UBS Group, an estimated $105K added.
  • The largest SeaStar Medical seller in Q2 2025 was Armistice Capital, an estimated $1.02M sold.

Based on aggregated 13F filings for Q2 2025.